The pharmacokinetics of THC in fat and brain: resulting functional responses to marihuana smoking

  title={The pharmacokinetics of THC in fat and brain: resulting functional responses to marihuana smoking},
  author={Gabriel G. Nahas},
  journal={Human Psychopharmacology: Clinical and Experimental},
  • G. Nahas
  • Published 1 April 2001
  • Biology, Chemistry, Medicine
  • Human Psychopharmacology: Clinical and Experimental
A pleasant sensory perception (PSP), the high of THC or of marihuana consumption, is a consistent functional response to this drug only manifested by man, and which occurs concurrently with an increased heart rate. However, it has not been possible to relate consistently magnitude and duration of these functional markers to THC plasma concentration, whatever the route of administration. A re‐analysis of all the available clinical and experimental data reporting the pharmacokinetics and storage… 
A double-blind, randomized, placebo-controlled, cross-over study on the pharmacokinetics and effects of cannabis
Smoking cannabis with higher THC contents was associated with a dose-related increase of the serum concentrations of THC (internal exposure) and psychomotor effects (such as reacting more slowly, being less concentrated, making more mistakes during testing, having decreased functioning of motor control, and having more drowsiness).
The relationship between cannabis use and taurine: A MRS and metabolomics study
This study shows the feasibility and potential importance of examining the relationship between taurine and CB use as it may shed light on a mechanism that underlies the neuroprotective effects of CB.
Cannabinoids for therapeutic use in atherosclerosis 1
In a mouse model of atherosclerosis, it is shown that THC inhibits disease progression through pleiotropic effects on inflammatory cells, and pharmacological modulation of the endocannabinoid system might also offer a new therapeutic strategy in the treatment of Atherosclerosis.
Cannabinoids, Blood–Brain Barrier, and Brain Disposition
Findings indicate that CBD can modify the deleterious effects on BBB caused by inflammatory cytokines and may play a pivotal role in ameliorating BBB dysfunction consequent to ischemia, supporting the therapeutic potential of CBD for the treatment of ischemic and inflammatory diseases of CNS.
Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis.
The identification and characterization of cannabinoid derivative that selectively activate CB(2) receptors and are devoid of adverse effects might offer a novel therapeutic strategy for the treatment of atherosclerosis.


Pharmacokinetics of THC in Inhaled and Oral Preparations
The topic of the pharmacokinetics of THC as illustrated by Harvey is very complex and includes protein binding, storage in the tissues, metabolism, active and inactive metabolites, as well as mechanisms of excretion through biliary excretion with enterohepatic recirculation, fecal excretion, and renal excretion.
The Kinetics of Cannabinoid Distribution and Storage With Special Reference to the Brain and Testis
After two weeks of chronic administration, concentrations of radioactivity progressively increased in liver and neutral fat, while cannabinoid levels in brain and testis remained unchanged, illustrating the efficiency of the blood‐brain and blood‐testicular barrier in limiting the access and accumulation of cannabinoids in these tissues.
Do Plasma Concentrations of Δ9‐Tetrahydrocannabinol Reflect the Degree of Intoxication?
Plasma concentrations of THC were measured by gas‐liquid chromatography and mass spectrometry following three routes of administration and correlated with clinical effects and it is unlikely that a range of plasma concentrations can be reliably equated with impaired performance.
Psychoactive cannabinoids and membrane signaling
It is proposed that the binding of AEA and 2‐AG to the G protein coupled transmembrane receptor possesses a physiological function which is to regulate the signaling between boundary lipids and membrane receptors in response to extracellular signals.
The Psychologic and Physiologic Effects of Active Cannabinoids
This communication reviews the pharmacologic effects observed when Δ9-THC and other cannabinoids were administered to humans by different routes of administration and concludes that this cannabinoid therapeutic application merits further investigation.
Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
It is concluded that, although there is a strong association between anesthetic-induced membrane disordering and desensitization, more detailed tests of a mechanistic nature will be necessary to elucidate the mechanisms underlying the Meyer-Overton-type behavior.
Marihuana: Studies on the Disposition and Metabolism of Delta-9-Tetrahydrocannabinol in Man
Δ9-Tetrahydrocannabinol (the major active component of marihuana) administered intravenously to normal human volunteers persists in plasma for more than 3 days (t1/2 = 56 hours). Its metabolites
Delta-9-Tetrahydrocannabinol: Localization in Body Fat
After a single injection, the concentration of Δ9THC in fat was ten times greater than in any other tissue examined, and persisted in this tissue for 2 weeks.